Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
What is the role for chemo immunotherapy in the up front setting in non-metastatic head & neck cancer outside of clinical trials?
Related Questions
For a patient s/p TORS with indications for adjuvant radiation, how does your management change with persistently elevated ctHPVDNA?
What is the role of radiation therapy for Kimura's disease of the parotid and neck?
What is the role of adjuvant RT for metastatic RCC to the thyroid resected with high-risk features?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
How would you approach post-op radiation recommendations in patients who had neoadjuvant chemoimmunotherapy for HPV mediated OPSCC s/p TORS who have a complete pathologic response (pCR)?
How would you counsel a patient concerned about receiving IMRT rather than IMPT for oropharyngeal cancer?
What are fractionation options for a patient with progressive jugular foramen paraganglioma now causing multiple cranial nerve deficits?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?
What alternatives do you recommend for oral dexamethasone solution for HN cancer?
